InterVaal is developing a catheter to address the widespread problem of catheter-associated urinary tract infection (CAUTI).
The “buffer zone” of the uniquely designed InterVaal catheter serves to keep the urethra flushed and to mitigate the migration of bacteria. The catheter design reduces the number of urinary tract infections caused by the presence of bacteria along the catheter.
Sam Lim, CEO: Over 10 years of R&D project management experience in medical device companies
Lu Shan, mechanical engineer: 4 years’ experience in product design, with a specialty in medical devices
Trendlines’ director: Eric Loh
Founded: September 2017
Stage: Technology development
Investors: The Trendlines Group, Trendlines Medical Singapore
IP: Provisional patent application
A urinary tract infection is an infection in the urinary system which includes the urethra, bladder and kidneys. CAUTIs occur due to the presence of bacteria that travel along the catheter and cause infection.
Sam Lim, CEO
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer
Endoscopic ultrasound fine needle biopsy system